What To Expect From Bristol Myers Squibb Stock After Q1 Results?
- Thursday, April 28, 2022, 7:28
- Market
- Add a comment
BMY stock has seen a 23% rise YTD, outperforming its peers and the broader markets, primarily due to an increase in dividends and boosting its share repurchase program.
About the Author
admin123 has written 23414 stories on this site.
